Bio-Reference Laboratories (BRLI)

Bio-Reference Laboratories (BRLI) Q1 2015 Results - Earnings Call Webcast
March 5, 2015 | Source: Seeking Alpha

Bio-Reference Laboratories' (BRLI) CEO Dr. Marc Grodman on Q1 2015 Results - Earnings Call Transcri
March 5, 2015 | Source: Seeking Alpha

Bio-Reference Laboratories' (BRLI) CEO Marc Grodman on Q4 2014 Results - Earnings Call Transcript
Dec. 18, 2014 | Source: Seeking Alpha

Bio-Reference Laboratories (BRLI) Q4 2014 Results - Earnings Call Webcast
Dec. 18, 2014 | Source: Seeking Alpha

Bio-Reference Laboratories' (BRLI) CEO Marc Grodman on Q3 2014 Results - Earnings Call Transcript
Aug. 27, 2014 | Source: Seeking Alpha

Bio-Reference Laboratories (BRLI) Q3 2014 Results - Earnings Call Webcast
Aug. 27, 2014 | Source: Seeking Alpha

Bio-Reference Laboratories' (BRLI) CEO Marc Grodman on Q2 2014 Results - Earnings Call Transcript
June 5, 2014 | Source: Seeking Alpha

Bio-Reference Laboratories Management Discusses Q1 2014 Results - Earnings Call Transcript
March 4, 2014 | Source: Seeking Alpha

Bio-Reference Laboratories Management Discusses Q4 2013 Results - Earnings Call Transcript
Dec. 19, 2013 | Source: Seeking Alpha

Q4 2013 Bio Reference Labs Inc Earnings Conference call (Webcast)
Dec. 19, 2013 | Source: Seeking Alpha

Bio-Reference Laboratories, Inc. Discusses Q3 2013 Results (Webcast)
Aug. 29, 2013 | Source: Seeking Alpha

Bio-Reference Laboratories Management Discusses Q3 2013 Results - Earnings Call Transcript
Aug. 29, 2013 | Source: Seeking Alpha

Bio-Reference Laboratories Management Discusses Q2 2013 Results - Earnings Call Transcript
June 6, 2013 | Source: Seeking Alpha

Bio-Reference Laboratories Management Discusses Q1 2013 Results - Earnings Call Transcript
Feb. 28, 2013 | Source: Seeking Alpha

Bio-Reference Laboratories Management Discusses Q4 2012 Results - Earnings Call Transcript
Dec. 6, 2012 | Source: Seeking Alpha

Bio-Reference Laboratories' CEO Discusses Q3 Results - Earnings Call Transcript
Aug. 30, 2012 | Source: Seeking Alpha

Bio-Reference Laboratories Inc. F3Q09 (Qtr End 07/31/09) Earnings Call Transcript
Sept. 2, 2009 | Source: Seeking Alpha

Bio-Reference Laboratories F1Q09 (Qtr End 1/31/09) Earnings Call Transcript
March 5, 2009 | Source: Seeking Alpha

Bio-Reference Laboratories, Inc. Q4FY08 Earnings Call Transcript
Dec. 18, 2008 | Source: Seeking Alpha

Bio-Reference Laboratories, Inc Q3 2008 Earnings Call Transcript
Sept. 10, 2008 | Source: Seeking Alpha

Bio-Reference Laboratories, Inc. F2Q08 (Qtr End 4/30/08) Earnings Call Transcript
June 5, 2008 | Source: Seeking Alpha

Recent filings

Prospectuses and communications, business combinations - March 23, 2023

Bio-Reference: Press Release, Dated March 22, 2023 - March 23, 2023

Other preliminary proxy statements - March 15, 2023

Bio-Reference Laboratories Just Filed Its Annual Report: Net Loss Per Ordinar... - March 10, 2023

Other definitive proxy statements - Feb. 9, 2023

Sander Gerber just issued a filing suggesting it has sold all of its Bio-Reference Laboratories - Feb. 7, 2023

Prospectuses and communications, business combinations - Jan. 25, 2023

Bio-Reference: Press Release, Dated January 24, 2023 Exhibit 99.1 - Jan. 25, 2023

Bio-Reference: Soliciting Material Pursuant To §240.14A-12 BRILLIANT ACQUISITION CORPORATION - Jan. 17, 2023

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or - Jan. 11, 2023

Other definitive proxy statements - Jan. 3, 2023

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or - Jan. 3, 2023

Bio-Reference: Press Release, Dated December 19, 2022 Exhibit 99.1 - Dec. 20, 2022

Prospectuses and communications, business combinations - Dec. 20, 2022

Other preliminary proxy statements - Dec. 7, 2022

Bio-Reference: Press Release, Dated November 18, 2022 Exhibit 99.1 - Nov. 18, 2022

Prospectuses and communications, business combinations - Nov. 18, 2022

Bio-Reference Laboratories Just Filed Its Quarterly Report: Net Loss Per Ordinar... - Nov. 14, 2022

Statement of acquisition of beneficial ownership by individuals - Nov. 10, 2022

Prospectuses and communications, business combinations - Oct. 19, 2022

Bio-Reference: Press Release, Dated October 19, 2022 - Oct. 19, 2022

Bio-Reference: Soliciting Material Pursuant To §240.14A-12 BRILLIANT ACQUISITION CORPORATION - Sept. 29, 2022

Prospectuses and communications, business combinations - Sept. 29, 2022

Entry into a Material Definitive - Sept. 29, 2022

Other definitive proxy statements - Sept. 26, 2022

Entry into a Material Definitive - Sept. 22, 2022

Prospectuses and communications, business combinations - Sept. 22, 2022

Other preliminary proxy statements - Sept. 15, 2022

Notification of inability to timely file Form 10-Q or 10-QSB - Aug. 15, 2022

Lawrence M. Feis just provided an update on share ownership of Bio-Reference Laboratories - Aug. 5, 2022

Bio-Reference: Press Release, Dated July 19, 2022 - July 19, 2022

Prospectuses and communications, business combinations - July 19, 2022

Other definitive proxy statements - June 28, 2022

Preliminary Proxy Soliciting materials - June 24, 2022

Termination of a Material Definitive - June 17, 2022

Other preliminary proxy statements - June 17, 2022

Prospectuses and communications, business combinations - May 19, 2022

Bio-Reference Laboratories Just Filed Its Quarterly Report: Net Loss Per Ordinar... - May 16, 2022

Prospectuses and communications, business combinations - May 4, 2022

Bio-Reference Laboratories director just picked up 5,000 shares - April 21, 2022

Sorry, no schedule available for this company

Brilliant Acquisition Corporation Announces Extension of Completion Window to March 23, 2023 - Feb. 23, 2023

Brilliant Acquisition Corporation Announces Extension of Completion Window to February 23, 2023 - Jan. 24, 2023

Brilliant Acquisition Corporation Announces Extension of Completion Window to January 23, 2023 - Dec. 19, 2022

Brilliant Acquisition Corporation Announces Extension of Completion Window to December 23, 2022 - Nov. 18, 2022

Brilliant Acquisition Corporation Announces Extension of Completion Window to November 23, 2022 - Oct. 19, 2022

Brilliant Acquisition Corp announces entry into material agreement with Nukkleus Inc. - Feb. 24, 2022

Nukkleus, Inc., a market leader in modern global payments and multi-asset trading technology, to combine with Brilliant Acquisition Corp. - Feb. 23, 2022

Brilliant Acquisition Corporation Announces Extension of Completion Window to March 25, 2022 - Dec. 23, 2021

Brilliant Acquisition Corporation Announces Extension of Completion Window to December 25, 2021 - Sept. 21, 2021

Brilliant Acquisition Corporation: New SEC Guidance Relating to SPAC Warrants, Its Effect on the Company’s Periodic Filings and Compliance with Nasdaq Rules - Aug. 31, 2021

Brilliant Acquisition Corporation Announces Timely Deposit of Additional Funds By Its Sponsor - June 28, 2021

Brilliant Acquisition Corporation Announces Extension of Completion Window to September 25, 2021 - June 22, 2021

Brilliant Acquisition Corporation: New SEC Guidance Relating to SPAC Warrants, Its Effect on the Company’s Periodic Filings and Compliance with Nasdaq Rules - June 8, 2021

Brilliant Acquisition Corporation: New SEC Guidance Relating to SPAC Warrants, Its Effect on the Company’s Periodic Filings and Compliance with Nasdaq Rules - April 19, 2021

Brilliant Acquisition Corporation Announces Separate Trading of its Ordinary Shares, Rights, and Warrants, Commencing July 22, 2020 - July 20, 2020

Brilliant Acquisition Corporation Announces Full Exercise of Overallotment Option - June 30, 2020

Brilliant Acquisition Corporation Announces Closing of $40 Million Initial Public Offering - June 26, 2020

BRILLIANT ACQUISITION CORPORATION ANNOUNCES PRICING OF $40 MILLION INITIAL PUBLIC OFFERING - June 23, 2020

 


Feedback